Breaking News

Allergan’s RESTASIS Approved with Aptar’s Ophthalmic Squeeze Dispenser

Becomes first FDA-approved multidose delivery system to handle Rx eye treatment formulations without preservatives

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Aptar Pharma’s preservative-free multidose Ophthalmic Squeeze Dispenser is available for patients in the U.S. for the first time with Allergan’s RESTASIS MULTIDOSE (Cyclosporine Ophthalmic Emulsion) for the treamtent of dry eye. Aptar works closely with Allergan to help improve patient safety, achieve dosing accuracy and maintain product integrity. Aptar’s Ophthalmic Squeeze Dispenser the first, and only, U.S. FDA- approved multidose delivery system to handle prescription ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters